Status:
COMPLETED
Mer-TK in Human Cardiac Cells
Lead Sponsor:
Ann & Robert H Lurie Children's Hospital of Chicago
Conditions:
Myocardial Inflammation
Myocardial Infarction
Eligibility:
All Genders
Up to 19 years
Brief Summary
The relationship between the immune system and the myocardium after myocardial ischemia is an evolving field of research. Crosstalk occurs between macrophages and cardiac myocytes to promote cardio-pr...
Eligibility Criteria
Inclusion
- All patient ages from birth-19 years-old as well as cyanotic and acyanotic cardiac lesions will be included
Exclusion
- Patients will be excluded if both pre and post bypass blood samples are not available.
Key Trial Info
Start Date :
May 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04322630
Start Date
May 10 2019
End Date
December 31 2020
Last Update
August 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann & Robert H Lurie Children's Hopsital
Chicago, Illinois, United States, 60611